loading...| Preferred Name |
Pancrelipase |
|
| Synonyms |
|
|
| Definitions |
A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C29345 |
|
| Accepted_Therapeutic_Use_For |
exocrine pancreatic insufficiency; pancreatic enzyme deficiency |
|
| CAS_Registry |
53608-75-6 |
|
| code |
C29345 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes. |
|
| Display_Name |
Pancrelipase |
|
| FDA_UNII_Code |
FQ3DRG0N5K |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
| label |
Pancrelipase |
|
| Legacy Concept Name |
Pancrelipase |
|
| NCI_Drug_Dictionary_ID |
43514 |
|
| PDQ_Closed_Trial_Search_ID |
43514 |
|
| PDQ_Open_Trial_Search_ID |
43514 |
|
| Preferred_Name |
Pancrelipase |
|
| prefixIRI |
NCIT:C29345 |
|
| prefLabel |
Pancrelipase |
|
| Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance |
|
| UMLS_CUI |
C0770343 |
|
| subClassOf |